Cargando…
Alterations in Gut Microbiota by Statin Therapy and Possible Intermediate Effects on Hyperglycemia and Hyperlipidemia
Dysbiosis of the gut microbiota is a contributing factor for obesity-related metabolic diseases such as hyperglycemia and hyperlipidemia. Pharmacotherapy for metabolic diseases involves the modulation of gut microbiota, which is suggested to be a potential therapeutic target. In this study, the modu...
Autores principales: | Kim, Jiyeon, Lee, Heetae, An, Jinho, Song, Youngcheon, Lee, Chong-Kil, Kim, Kyungjae, Kong, Hyunseok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6736992/ https://www.ncbi.nlm.nih.gov/pubmed/31551944 http://dx.doi.org/10.3389/fmicb.2019.01947 |
Ejemplares similares
-
Downregulation of IL-18 Expression in the Gut by Metformin-induced Gut Microbiota Modulation
por: Lee, Heetae, et al.
Publicado: (2019) -
Modulation of Pro-inflammatory and Anti-inflammatory Cytokines in the Fat by an Aloe Gel-based Formula, QDMC, Is Correlated with Altered Gut Microbiota
por: An, Jinho, et al.
Publicado: (2021) -
Restoration of Declined Immune Responses and Hyperlipidemia by Rubus occidenalis in Diet-Induced Obese Mice
por: Lee, Youngjoo, et al.
Publicado: (2017) -
A Novel Bacterium, Butyricimonas virosa, Preventing HFD-Induced Diabetes and Metabolic Disorders in Mice via GLP-1 Receptor
por: Lee, Heetae, et al.
Publicado: (2022) -
Multifaceted Effect of Rubus Occidentalis on Hyperglycemia and Hypercholesterolemia in Mice with Diet-Induced Metabolic Diseases
por: Kim, Jiyeon, et al.
Publicado: (2018)